首页
外语
计算机
考研
公务员
职业资格
财经
工程
司法
医学
专升本
自考
实用职业技能
登录
外语
In an age where people promiscuously post personal data on the web and regularly click "I agree" to reams of legalese they have
In an age where people promiscuously post personal data on the web and regularly click "I agree" to reams of legalese they have
admin
2014-09-09
68
问题
In an age where people promiscuously post personal data on the web and regularly click "I agree" to reams of legalese they have never read, news of yet another electronic consent form might seem like a big yawn. But for the future of genomics-related research the Portable Legal Consent, to be announced shortly by Sage Bionetworks, a non-profit research organisation based in Seattle, is anything but mundane. Indeed, by reversing the normal way consent to use personal data is acquired from patients in clinical trials, it could spell a new relationship between scientists and the human subjects of their research, with potential benefits that extend well beyond genomics.
The heart of Portable Legal Consent is the notion that anyone who signs up for a clinical trial, or simply has his genome read in order to anticipate the risk of disease, should easily be able to share his genomic and health data not just with that research group or company, but with all scientists who are prepared in turn to accept some sensible rules about how they may use the data. The main one of these is that the results of investigations which include such "open source" data must, themselves, be freely and publicly available. In much the same vein as the open-source-software movement, the purpose of this is to increase the long-term value of the data, by allowing them to be reused in ways that may not even have been conceived of at the time they were collected.
That approach contrasts with today’s system of secretive data silos for particular studies of specific diseases. Patients sometimes discover that they have even signed away their rights to see their own data. That may serve the narrow interests of a research group or drug company intent on keeping competitors at bay. But the potential of genomic data to provide further insights, perhaps in completely novel contexts, is huge. Also, teasing out correlations between particular genotypes and diseases in a statistically meaningful way requires large sets of data; the larger the set, the more believable the correlations. Portable Legal Consent brings the promise of very large data sets indeed.
Even for academia and industry, these benefits should eventually outweigh the short-term drawbacks of sharing. Indeed, according to John Wilbanks, the creator of Portable Legal Consent, representatives of several drug companies have expressed enthusiasm about Sage Bionetworks’ approach. And appealing features, such as so-called syndicating technology, which automatically informs both researchers and volunteers about new data relevant to a specific drug or disease, should reduce the resistance of individual researchers to the loss of control of what they used to think of as their own data. Of course, sharing in this open-ended way carries risks. The data involved are "de-identified"—meaning they cannot immediately be traced to a specific individual. But as Mr Wilbanks notes, this is not a foolproof guarantee of anonymity.
Data shared might, for example, be traced back to their owner by sophisticated search algorithms. Or some malevolent hacker might expose them to the world. Those squeamish about sharing their personal information should probably not sign the consent form, Mr Wilbanks counsels. But those who believe the benefit of doing so—accelerating the pace of medical research— outweighs the risks can start to pool their own data next month on a special website: weconsent. us. To make sure consent is truly informed, Mr Wilbanks and his team have gone to great lengths to explain the consequences to signatories. There is an online tutorial that cannot be bypassed. Uploaded information may be removed from the database on request, at any time, but the provider is clearly warned that it may have already found its way into places from which it cannot be erased.
Sage Bionetworks hopes 25,000 people will sign up in the first year, either because trial organisers choose to adopt the protocol or volunteers insist on it. But to be really useful, the database would need to grow to ten or 100 times this size. Mr Wilbanks has therefore started discussions with several firms that offer commercial genetic tests for a range of diseases. It is also linking up with an organisation that helps almost 150,000 people find those with similar illnesses, in order to share their experiences.
So far, the Portable Legal Consent is valid only in America, although Sage Bionetworks is looking at ways of adapting it to fit the legal frameworks of China and the EU. How quickly the idea will catch on remains to be seen. But if it does, other sorts of researchers who rely on gathering personal data—for example in sociology or in tracking energy use in homes—may find it attractive. And that would enable research of a sort that is now impossible, by opening up the field of quantifiable social science.
What are the possible advantages of this consent?
选项
答案
allow to establish a sort of "open source" data/the results of such investigations "freely and publicly available"/to increase the "long term value of the data’Vallowed to be reused in ways "that may not even have been imagined" or expected at the time of collection/sharp contrast with today’s popular "system of secretive data silos"
解析
转载请注明原文地址:https://kaotiyun.com/show/nXSO777K
本试题收录于:
NAETI高级口译笔试题库外语翻译证书(NAETI)分类
0
NAETI高级口译笔试
外语翻译证书(NAETI)
相关试题推荐
MostpeoplewouldbeimpressedbythehighqualityofmedicineavailabletomostAmericans.Thereisalotofspecialization,a
MostpeoplewouldbeimpressedbythehighqualityofmedicineavailabletomostAmericans.Thereisalotofspecialization,a
MostpeoplewouldbeimpressedbythehighqualityofmedicineavailabletomostAmericans.Thereisalotofspecialization,a
MostpeoplewouldbeimpressedbythehighqualityofmedicineavailabletomostAmericans.Thereisalotofspecialization,a
Modernindustrialsocietygrantslittlestatustooldpeople.Infact,suchasocietyhasasystemofbuilt-inobsolescence.The
Inmanycountriestobaccoandmedicinearegovernment________.
Fornearlyacentury,twoUnitedStatesgovernmentalagencies,theUnitedStatesArmyCorpsofEngineersandtheBureauofRecla
Fornearlyacentury,twoUnitedStatesgovernmentalagencies,theUnitedStatesArmyCorpsofEngineersandtheBureauofRecla
随机试题
患者,叶某,男,67岁,退休教师,诊断“肺癌晚期”入院,入院后患者诉说胸痛难以忍受,沉默寡言,眉头紧锁,咳嗽频繁并有气喘,难以交流。请问作为主管护士:你应了解哪些主观因素影响其疼痛?
属于营养必需氨基酸的是
A.枸橼酸乙胺嗪B.吡喹酮C.阿苯达唑D.甲硝唑E.蒿甲醚
专利实施许可合同的被许可人无权允许合同规定以外的任何单位或者个人实施该专利。( )
购入材料时支付的增值税进项税额和进口关税均应计入采购成本。()
某生产企业(一般纳税人)因意外事故损失外购钢材30万元.保险公司词查后同意赔付4万元,其余损失已报经税务机关同意扣除。则该企业确定应纳税所得额时正确的有()。
地坛又名方泽坛,始建于明代,呈正方形。()
神舟七号载人飞船飞行的圆满成功告诉世界,中国不是一个只能生产鞋、袜子、打火机的国家.还可以制造宇宙飞船,“中国制造”在世界市场上的底气也因此而变强。由此可以反映出来的经济学道理是()。
你作为审计人员,去一家企业审计一笔财务资金的线索。企业的财务经理李明一直沉默不语,你怎么和李明沟通?请现场模拟。
Theconceptionofpovertyandwhatto【C1】______aboutithavechangedoverthedecades.UnderSocialDarwinismthelazyandthe【C
最新回复
(
0
)